Article
Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
Malaria journal - 20 Jul 2023
Tarama Casimire Wendlamita, Soré Harouna, Siribié Mafama, Débé Siaka, Kinda Réné, Ganou Adama, Nonkani Wendyam Gérard, Tiendrebeogo Farida, Bantango Winnie, Yira Kassoum, Sagnon Aladari, Ilboudo Sonia, Hien Esther Yéri, Guelbéogo Moussa Wandaogo, Sagnon NFale, Traoré Yves, Ménard Didier, Gansané Adama
Abstract excerpt
BACKGROUND: Artemisinin-based combinations therapy (ACT) is the current frontline curative therapy for uncomplicated malaria in Burkina Faso. Sulfadoxine-pyrimethamine (SP) is used for the preventive treatment of pregnant women (IPTp), while SP plus amodiaquine (SP-AQ) is recommended for children under five in seasonal malaria chemoprevention (SMC). This study aimed to assess the proportions of mutations in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
